Compounds > methylprednisolone

methylprednisolone and enalapril

methylprednisolone has been researched along with enalapril in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (18.75)	18.2507
2000's	7 (43.75)	29.6817
2010's	6 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Alegret, F; Baena Diez, JM; Carreras Soler, MJ; Durán Pou, S; Juarez Gimenez, JC	1
Breiteneder, S; Hörl, WH; Schmaldienst, S; Winkler, S	1
Dzikova, S; Grcevska, L; Grozdanovski, R; Polenaković, M	1
Alessandri, C; Angelico, F; Del Ben, M; Di Biasi, C; Scorza, A; Trasimeni, G	1
Andreoli, SP; Phillips, CL; Tibbs, ME	1
Cárdenas Ochoa, EC; Hernández Flores, G; Sahagún Flores, JE; Soto Ortiz, JA; Tovar Méndez, CE	1
Alvarez-Ude, F; Fernández-Reyes, MJ; Heras, M; Pardo, J; Saiz, A; Sánchez, R	1
Chang, YW; Cheng, HT; Liao, MT; Lin, WC; Lin, YH; Tsai, IJ; Tsau, YK	1

Reviews

1 review(s) available for methylprednisolone and enalapril

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

15 other study(ies) available for methylprednisolone and enalapril

Article	Year
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7 Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Angioneurotic edema produced by enalapril. The Annals of pharmacotherapy, 1995, Volume: 29, Issue:3 Topics: Aged; Angioedema; Enalapril; Female; Humans; Methylprednisolone	1995
Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Cyclosporine; Enalapril; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl CoA Reductases; IgA Vasculitis; Immunosuppressive Agents; Lovastatin; Male; Methylprednisolone; Middle Aged; Nephrotic Syndrome; Plasmapheresis; Prednisone; Proteinuria	1997
Acute renal failure with severe tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with enalapril. Clinical nephrology, 1997, Volume: 48, Issue:5 Topics: Acute Kidney Injury; Adult; Cyclophosphamide; Enalapril; Humans; Kidney; Kidney Tubules; Male; Methylprednisolone; Microscopy, Electron; Nephrosis, Lipoid; Prednisone	1997
Tolosa-Hunt syndrome. Report of a case in clinical practice. Panminerva medica, 2003, Volume: 45, Issue:2 Topics: Antihypertensive Agents; Enalapril; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Tolosa-Hunt Syndrome	2003
Membranoproliferative glomerulonephritis type II in a 10-year-old girl. Clinical laboratory science : journal of the American Society for Medical Technology, 2005,Spring, Volume: 18, Issue:2 Topics: Child; Clinical Chemistry Tests; Diagnosis, Differential; Drug Therapy, Combination; Enalapril; Female; Fluorescent Antibody Technique, Direct; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Hematologic Tests; Humans; Hypertension; Kidney Diseases; Kidney Glomerulus; Methylprednisolone; Prednisone; Treatment Outcome	2005
[Stevens-Johnson syndrome plus intrahepatic cholestasis caused by clindamycin or chlorpheniramine]. Dermatology online journal, 2009, May-15, Volume: 15, Issue:5 Topics: Acetaminophen; Betamethasone; Bronchitis; Chlorpheniramine; Cholestasis, Intrahepatic; Clindamycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enalapril; Female; Foot Dermatoses; Hand Dermatoses; Humans; Insulin; Methylprednisolone; Middle Aged; Mucositis; Stevens-Johnson Syndrome	2009
[Rapidly progressive renal failure as the onset of an IgA nephropathy in an elderly patient]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:2 Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Biphenyl Compounds; Disease Progression; Diuretics; Doxazosin; Drug Therapy, Combination; Enalapril; Furosemide; Glomerulonephritis, IGA; Humans; Irbesartan; Male; Methylprednisolone; Nocturia; Prednisone; Prostatic Neoplasms; Remission Induction; Renal Dialysis; Tetrazoles	2011
A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy. Clinical nephrology, 2012, Volume: 78, Issue:3 Topics: Age of Onset; Anti-Inflammatory Agents; Antihypertensive Agents; Apolipoprotein E2; Child; Enalapril; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methylprednisolone; Mutation; Nephrotic Syndrome; Pravastatin	2012